PTC Therapeutics, a global biopharmaceutical company that delivers transformative therapies for children and adults living with rare diseases, celebrated its tenth anniversary of operations in Dublin, Ireland with the opening of a new office. The site, which serves as the company’s international headquarters, is designed to support PTC’s future growth and impact across the region. The site will play a key role in the company’s expanding commercial portfolio and pipeline, ensuring PTC’s innovative medicines reach more patients worldwide.
“We are proud to celebrate a decade of operations in Ireland and of the impact we’ve made through initiatives that help to improve outcomes and support children and adults with rare diseases,” said Adrian Haigh, Company Director Ireland and Head of Emerging Markets. “Our Dublin site has been instrumental in the company’s regional success and global growth, and our new office will remain important to our global and multidisciplinary teams as a vibrant international hub.”
PTC Ireland is responsible for the global supply chain of PTC rare disease therapies, ensuring that life-changing medicines are manufactured with high quality and distributed to more than 50 countries around the world. With nine departments and more than 50 employees, the teams in Dublin also manage global quality operations, global pharmacovigilance activities, and commercial sales and finances for Europe, Middle East and Africa (EMEA) and Asia Pacific (APAC) regions.
“In the last decade we have deepened our roots in Dublin with a sustainable growth strategy,” said Melissa Kenny, Company Director Ireland and Vice President of Finance Excellence. The team’s expertise and efforts have been instrumental in driving innovation across the business, fostering international collaborations and making a positive impact in the local and global communities PTC serves. With a strong corporate culture and a commitment to investing in talent development and offering rewarding employment opportunities, PTC Ireland aims to sustain a presence as an employer of choice in Ireland.
“At PTC, people are our greatest asset and we continue to invest in people and workplace initiatives that are designed to foster inclusion, growth and a sense of belonging within our organization. We are leading progress in gender representation and are proud of our 60% female leadership in Ireland, as well as employees from varied backgrounds and nationalities working collaboratively with a common purpose,” stated Patrice Thornton, Vice President Human Resources.
Rachel Shelly, Global Head of Life Sciences, IDA Ireland said: ‘’Congratulations to PTC Therapeutics on reaching their ten-year milestone in Ireland. This marks a new chapter in their journey of innovation and providing support for those living with rare diseases. I look forward to their further contributions to Ireland’s thriving life sciences community in the years to come.’’
“We are proud to celebrate a decade of operations in Ireland and of the impact we’ve made through initiatives that help to improve outcomes and support children and adults with rare diseases,” said Adrian Haigh, Company Director Ireland and Head of Emerging Markets. “Our Dublin site has been instrumental in the company’s regional success and global growth, and our new office will remain important to our global and multidisciplinary teams as a vibrant international hub.”
PTC Ireland is responsible for the global supply chain of PTC rare disease therapies, ensuring that life-changing medicines are manufactured with high quality and distributed to more than 50 countries around the world. With nine departments and more than 50 employees, the teams in Dublin also manage global quality operations, global pharmacovigilance activities, and commercial sales and finances for Europe, Middle East and Africa (EMEA) and Asia Pacific (APAC) regions.
“In the last decade we have deepened our roots in Dublin with a sustainable growth strategy,” said Melissa Kenny, Company Director Ireland and Vice President of Finance Excellence. The team’s expertise and efforts have been instrumental in driving innovation across the business, fostering international collaborations and making a positive impact in the local and global communities PTC serves. With a strong corporate culture and a commitment to investing in talent development and offering rewarding employment opportunities, PTC Ireland aims to sustain a presence as an employer of choice in Ireland.
“At PTC, people are our greatest asset and we continue to invest in people and workplace initiatives that are designed to foster inclusion, growth and a sense of belonging within our organization. We are leading progress in gender representation and are proud of our 60% female leadership in Ireland, as well as employees from varied backgrounds and nationalities working collaboratively with a common purpose,” stated Patrice Thornton, Vice President Human Resources.
Rachel Shelly, Global Head of Life Sciences, IDA Ireland said: ‘’Congratulations to PTC Therapeutics on reaching their ten-year milestone in Ireland. This marks a new chapter in their journey of innovation and providing support for those living with rare diseases. I look forward to their further contributions to Ireland’s thriving life sciences community in the years to come.’’